Osteopontin Enhances Endogenous Repair After Neonatal Hypoxic–Ischemic Brain Injury

Repeated Mesenchymal Stem Cell Treatment after Neonatal Hypoxia-Ischemia Has Distinct Effects on Formation and Maturation of New Neurons and Oligodendrocytes Leading to Restoration of Damage, Corticospinal Motor Tract Activity, and Sensorimotor Function

(2013) C. T. J. van Velthoven et al.   JOURNAL OF NEUROSCIENCE

Protective effects of recombinant osteopontin on early brain injury after subarachnoid hemorrhage in rats*

(2010) Hidenori Suzuki et al.   CRITICAL CARE MEDICINE

Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration

(2009) Cindy T.J. van Velthoven et al.   BRAIN BEHAVIOR AND IMMUNITY

Growth factors improve neurogenesis and outcome after focal cerebral ischemia

(2009) Ronen Robert Leker et al.   JOURNAL OF NEURAL TRANSMISSION

Persistent migration of neuroblasts from the subventricular zone to the injured striatum mediated by osteopontin following intracerebral hemorrhage

(2009) Yi-Ping Yan et al.   JOURNAL OF NEUROCHEMISTRY

Osteopontin Expression Correlates with Angiogenesis and Survival in Malignant Astrocytoma

(2009) Koviljka Matusan-Ilijas et al.   PATHOLOGY & ONCOLOGY RESEARCH